Drug Shortage Report for VAQTA

Last updated on 2018-03-27 History
Report ID 32720
Drug Identification Number 02229702
Brand name VAQTA
Common or Proper name hepatitis A vaccine, purified inactivated Suspension for injection
Company Name MERCK CANADA INC
Active Ingredient(s) HEPATITIS A VACCINE, INACTIVATED
Strength(s) 50UNIT
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR
Packaging size 50U/1ML 1DOSE VIAL (ADULT)
ATC code J07BC
ATC description VIRAL VACCINES
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2018-02-02
Actual start date 2018-01-11
Estimated end date 2018-03-26
Actual end date 2018-03-26
Shortage status Resolved
Updated date 2018-03-27
Company comments Remaining doses are reserved for the public immunization program.
Health Canada comments
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2018-03-27 English Compare
v9 2018-03-26 English Compare
v8 2018-03-16 English Compare
v7 2018-01-24 French Compare
v6 2018-01-24 English Compare
v5 2018-01-12 English Compare
v4 2018-01-11 French Compare
v3 2018-01-11 English Compare
v2 2017-12-13 French Compare
v1 2017-12-13 English Compare